BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Geron Corporation and FDA Reach Agreement on Clinical Hold

  October 30, 2009

   · 

  1 min read
• Pharm Country

  Pfizer Inc.’s Board Of Directors Approves Shareholder Advisory Vote On Executive Compensation

  October 30, 2009

   · 

  1 min read
• Drug Development

  ExonHit Therapeutics Inc. Presents New Clinical Advances on Its Alzheimer’s Diagnostic and Therapeutic Programs

  October 30, 2009

   · 

  1 min read
• Business

  Celera Corporation (JOBS) Licenses Lung Cancer Intellectual Property from Medical Therapies Limited

  October 30, 2009

   · 

  1 min read
• Business

  Eli Lilly and Company (JOBS) Opens Biotech Center in San Diego; Nearly 200 Scientists to Key on Cancer, Diabetes, Autoimmune Ills

  October 30, 2009

   · 

  7 min read
• Drug Development

  Eisai Inc. (JOBS): Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival

  October 30, 2009

   · 

  4 min read
• Lone Star Bio

  Repros Therapeutics Inc. Announces Settlement with Major Creditors

  October 30, 2009

   · 

  1 min read
• Novo Nordisk A/S: Director/PDMR Shareholding

  October 30, 2009

   · 

  7 min read
• BioMidwest

  Thermo Fisher Scientific Names Recipients of RNAi Discovery Grants

  October 30, 2009

   · 

  5 min read
• Drug Development

  Affymax, Inc. and Takeda Global Research & Development Center, Inc. Announce Preliminary Phase 2 Data Demonstrated That Hematide(TM) Increased Hemoglobin in Dialysis Patients

  October 30, 2009

   · 

  1 min read